JAZZ

GWPH Stock: 12 Things to Know About the GW Pharma-Jazz Pharma Deal

By William White, InvestorPlace Writer
GW Pharmaceuticals (GWPH) stock is soaring higher on Wednesday following news that Jazz Pharmaceuticals (JAZZ) is acquiring the company.

7 Pharmaceutical Stocks With Exciting Plans for 2021

By Bret Kenwell, InvestorPlace Contributor
Pharmaceutical stocks have many benefits, particularly when their products are in demand. And in 2021, that seems likely to be the case.

This Coronavirus Crisis Will Mint Millionaires

By InvestorPlace Research Staff
History shows that not only is there an opportunity to buy during a crisis, but that the best performers are the small caps.

10 Best-Performing Growth Stocks of the 2010s

By Will Healy, InvestorPlace Contributor
These ten growth stocks saw the highest percentage growth over the last decade, and some remain unknown to investors despite huge increases.

5 GARP Stocks To Buy Today

By Aaron Levitt, InvestorPlace Contributor
In this rocky environment, investors should get to know GARP stocks for growth and value. These five stocks offer the best of both worlds.

5 Biotech Stocks That Could Face M&A Next!

By Aaron Levitt, InvestorPlace Contributor
Big biotech buyouts have already started happening. These five biotech stocks could be the next to go.

5 Safe Stocks to Buy With Low Price-to-Book Ratios

By
P/B ratio is a convenient tool to identify low-priced stocks that have high-growth prospects. Here are five stocks with low P/B ratios.

5 Low-Cost Biotech Stocks With High Levels of Growth

By Will Healy, InvestorPlace Contributor
These five biotech stocks balance low valuation with high growth and a track record of profits.

8 Undervalued Biotech Stocks to Watch

By Josh Enomoto, InvestorPlace Contributor
Volatility across all categories of biotech stocks makes this present juncture an ideal time to consider picking up undervalued names.

5 Low Price-to-Book Stocks Worth Buying in July

By
P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high-growth prospects. Compare Brokers....

10 Pharmaceuticals Stocks to Sell Now

By Portfolio Grader
This week, the ratings of 10 Pharmaceuticals stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Is 70% an Excessive Premium for Celator Pharmaceuticals Inc? (CPXX JAZZ)

By John Divine, InvestorPlace Assistant Editor
Jazz Pharmaceuticals stock is hovering around breakeven after agreeing to acquire Celator (CPXX) for a 73% premium. Does the deal make sense?

9 Biotech Stocks That Will Go Boom or Bust

By James Brumley, InvestorPlace Feature Writer
A bunch of biotech stocks are knocking on the door of news that could prove to be very good or very bad.

4 (More) Biotech Stocks to Buy

By James Brumley, InvestorPlace Feature Writer
Jazz Pharmaceuticals, bluebird bio, Illumina and Celgene are the latest batch of biotech stocks worth serious consideration.

2 Biotech Stocks to Buy After Earnings

By Louis Navellier, Editor, Growth Investor
Actavis (ACT) and Jazz Pharmaceuticals (JAZZ) reported outstanding Q3 earnings and are strong biotech stocks to buy.

10 Stocks with 5-Year Returns of 1,500%-Plus

By Jeff Reeves
The S&P has roughly doubled in the past five years, but these 10 stocks blow that performance out of the water, with gains of 1,500% or more.

Say Yes to Drugs with a Jazz Pharmaceuticals Credit Spread (JAZZ)

By John Kmiecik, InvestorPlace Contributor
Two of Jazz Pharmaceuticals' drugs are showing record growth, and the stock just keeps making new highs. Can it last?

5 Pharmaceutical Stocks to Buy Now

By Portfolio Grader
This week, five Pharmaceutical stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").

A Healthy Portfolio Is Heavy in Health Care

By Jeff Reeves
Investors would be foolish to ignore the massive demographic shift and growth potential that is boosting health care stocks right now.
Load More